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Background
HIV-1 group-M exhibits extraordinary genetic variation,
cross-reactivity of immunogens based on consensus
clades could be continuously diminishing as the AIDS
epidemic progresses. Characterisation of cross-reactive T-
cell responses to more central group M consensus pep-
tides in this multi-clade population has not been per-
formed; and could be pertinent for global vaccine
Methods
Fifty, randomly selected, HIV-1 chronically infected, ART-
naïve, Ugandan adults with CD4 ≥ 350 cells/μl were
screened for consensus group-M Gag and Nef-induced
IFN-γ using ELISpot. Gag sequence diversity was evaluated
and correlated with IFN-γ.
Results
Clades A1, D, and inter-subtype recombinants A1/C, A1/
D occurred at frequencies 44%, 51%, 2.4% and 2.4%, (n
= 41), respectively. Infecting gag sequences highly
diverged from consensus group-M (median 9.2: inter-
quartile range (IQR) 8.6–10%), and reveled evidence of
immunological pressure. Inter-clade divergence was
above the 3% threshold in clades A1 (5.3: 4.8–5.8%) and
D (6.1: 5.8–6.9%). High avidity Gag (96: 19–267 ng/ml)
and Nef-induced IFN-γ responses (74: 12–159 ng/ml)
were detected. All gag regions were recognized, highest
magnitudes were to p24. Gag was more targeted than Nef
(44/50[88%] vs. 32/50[64%]; p = 0.014, Fisher's Exact);
and induced higher IFN-γ magnitude (2420, 625–6445
vs. 475: 0–2000 SFU/106 PBMCs; p = 0.0003) and
breadth (2: 1–3 vs. 1: 0–1 epitopes; p = 0.0001, Mann-
Whitney), respectively, with no detectable difference
between clades. Nef-induced IFN-γ responses targeted the
conserved core region, and depicted lower magnitude (0:
0–765 vs. 1090: 275–2310 SFU/106 PBMCs; p = 0.04)
and breadth in clade A1 than D (0: 0–1 vs. 1: 1–2
epitopes; p = 0.03), respectively.
Conclusion
Robust, cross-reactive, HIV-1 consensus group-M cellular
responses in this highly diverse virus population implies
a potential for a vaccine using immunogens based on
these sequences despite the increasing diversity over time.
Nef responses correlated with clade D known to be linked
with faster disease progression; data suggests particular
focus on Gag previously also shown to correlate with pro-
tection in this population.
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